as 11-21-2024 10:36am EST
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Founded: | 1987 | Country: | United States |
Employees: | N/A | City: | SOUTH JORDAN |
Market Cap: | 5.8B | IPO Year: | 1990 |
Target Price: | $103.70 | AVG Volume (30 days): | 443.5K |
Analyst Decision: | Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.05 | EPS Growth: | 19.39 |
52 Week Low/High: | $65.46 - $105.46 | Next Earning Date: | 10-30-2024 |
Revenue: | $1,325,871,000 | Revenue Growth: | 8.12% |
Revenue Growth (this year): | 9.36% | Revenue Growth (next year): | 9.09% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Millner F. Ann | MMSI | Director | Nov 15 '24 | Sell | $101.55 | 12,500 | $1,269,375.00 | 32,391 | |
Parra Raul Jr. | MMSI | CFO AND TREASURER | Nov 7 '24 | Sell | $102.18 | 5,361 | $547,786.98 | 16,361 | |
Peterson Neil | MMSI | CHIEF OPERATING OFFICER | Nov 5 '24 | Sell | $98.00 | 5,000 | $490,000.00 | 14,819 | |
Parra Raul Jr. | MMSI | CFO AND TREASURER | Nov 5 '24 | Sell | $98.02 | 29,646 | $2,905,900.92 | 16,361 |
MMSI Breaking Stock News: Dive into MMSI Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Argus Research
9 days ago
Zacks
13 days ago
MT Newswires
13 days ago
Zacks
14 days ago
Argus Research
16 days ago
Zacks
16 days ago
Zacks
17 days ago
The information presented on this page, "MMSI Merit Medical Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.